PART I
We are a blank check company incorporated on January 21, 2021 as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Annual Report on Form 10-K as our initial business combination. We seek to advance the innovation economy by offering an alternate path to the public markets and partner with founders, operators and entrepreneurs to build a successful public company. To date, our efforts have been limited to organizational activities as well as activities related to the Initial Public Offering. Since the Initial Public Offering in November 2021, we have held introductory conversations with a number of companies. While we have not selected a target for a business combination, our team has identified several potential target companies that it believes are compelling opportunities for a business combination. There are ongoing discussions about the suitability of those potential target companies and we have commenced discussions with several such companies - directly and through intermediaries. We have generated no operating revenues to date, and we do not expect that we will generate operating revenues until we consummate our initial business combination.
On February 3, 2021, CBG and CB Co-Investment paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of an aggregate of 8,625,000 Class B ordinary shares. CBG purchased 7,195,714 of the Class B Shares and CB Co-Investment purchased 1,429,286 of the Class B Shares. On April 9, 2021, CB Co-Investment transferred 28,571 Class B Shares to CBG at their original purchase price. On October 1, 2021, CBG forfeited 2,408,095 and CB Co-Investment forfeited 466,905 Class B Shares, in each case, for no consideration. On November 9, 2021, CBG transferred an aggregate of 156,000 Class B Shares to three of the Company’s directors, the chief financial officer and two of the Company’s advisors. As a result, CBG owned 4,660,190 Class B Shares and CB Co-Investment owned 933,810 Class B Shares. On October 13, 2022, Nathanial Fick agreed to a transfer all 25,000 of the Class B Shares held by Mr. Fick to CBG.
On November 15, 2021, the Company consummated the Initial Public Offering of 23,000,000 units, including the issuance of 3,000,000 units as a result of the underwriters’ exercise in full of their over-allotment option. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment. The units were sold at an offering price of $10.00 per unit, generating gross proceeds to the Company of $230,000,000. Simultaneously with the consummation of the Initial Public Offering and the issuance and sale of the units, the Company consummated the private placement of 10,550,000 private placement warrants (including 1,050,000 private placement warrants purchased in connection with the exercise of the underwriters’ over-allotment option) at a price of $1.00 per private placement warrant, generating total gross proceeds of $10,550,000. In addition, upon closing of the Initial Public Offering, CB Co-Investment loaned the Company approximately $1,150,000 at no interest.
On May 10, 2023, the Company, CBG, and CB Co-Investment entered into non-redemption agreements with several unaffiliated third parties in exchange for such third parties agreeing not to redeem an aggregate of 4,000,000 ordinary shares of the Company sold in its IPO at an extraordinary general meeting of its shareholders held on May 12, 2023 (the “Special Meeting”). In exchange for the foregoing commitments not to redeem such shares, our sponsor and CB Co-Investment, as applicable, agreed to transfer to such third parties an aggregate of 1,000,000 ordinary shares of the Company held by our sponsor or CB Co-Investment, as applicable, plus up to an additional aggregate of 500,000 ordinary shares of the Company held by our sponsor or CB Co-Investment, as applicable, with such number of additional ordinary shares of the Company to be determined based upon the date of the consummation of the Company’s initial business combination. Such transfer of ordinary shares of the Company shall be effected immediately following the consummation of the Company’s business combination if such third party or third parties continued to hold such shares through the Special Meeting. In connection with such shareholder vote, the holders of an aggregate of 18,848,866 Class A Shares of the Company exercised their right to redeem their shares for an aggregate of approximately $197,854,025 in cash held in the trust account.
At the Special Meeting, the shareholders of the Company approved the amendment to the Company’s amended and restated memorandum and articles of incorporation, which extended the date to consummate an initial business combination from May 15, 2023 to November 15, 2023, and allowed the Board, without another shareholder vote, to elect to further extend the date to consummate an initial business combination after November 15, 2023 up to three times, by an additional month each time, up to February 15, 2024. The Company’s Board elected to extend the date in each of those additional three months until February 15, 2024.
On December 29, 2023 (the “Closing Date”), the Company, CBG, CB Co-Investment and Fulton AC, consummated the transactions contemplated by that certain Securities Purchase Agreement (the “Securities Purchase Agreement”), dated December 8, 2023, pursuant to which Fulton AC acquired from the CBG and CB Co-Investment an aggregate of (i) 3,035,000 Class B Ordinary